Production and Quality Control of Actinium-225 Radiopharmaceuticals
IAEA-TECDOC-2057
ISBN
978-92-0-121324-2
54 pages | 20 figures | € 30.00 | Date published: 2024
This publication includes existing experiences, lessons learned, challenges and future developments in the production of Ac-225 radiopharmaceuticals for Targeted Alpha Therapy (TAT). This publication will be utilized by all involved professionals in the Targeted Alpha Therapy field, specifying ideal production, formulation, quality control and regulatory aspects of various Ac-225 radiopharmaceuticals. The intended audience also includes radiochemists, radiopharmacists, and medical physicists.
Keywords:
Production and Quality Control, Actinium-225, Ac-225, Radiopharmaceuticals, Targeted Alpha Therapy, TAT, Formulation, Quality Control, Radiopharmacists, Medical Physicists, Safety Measures, Production Control, Nuclear Medicine, Alpha Emitting Radionuclides, Clinical Use of Ac-225, Actinium-225 Production, Radiochemical Separation, Irradiation, Staff Requirements, Radiopharmaceutical Production, Radiolabelling, Radiation Protection, Shipment of Alpha Emitters, Waste Management, Radiation Safety for Patients
